In all animal cells, phospholipids are asymmetrically distributed between the outer and inner leaflets of the plasma membrane 1 . This asymmetrical phospholipid distribution is disrupted in various biological systems. For example, when blood platelets are activated, they expose phosphatidylserine (PtdSer) to trigger the clotting system 2, 3 . The PtdSer exposure is believed to be mediated by Ca 21 dependent phospholipid scramblases that transport phospholipids bidirectionally 1, 4 , but its molecular mechanism is still unknown. Here we show that TMEM16F (transmembrane protein 16F) is an essential component for the Ca 21 -dependent exposure of PtdSer on the cell surface. When a mouse B-cell line, Ba/F3, was treated with a Ca 21 ionophore under low-Ca 21 conditions, it reversibly exposed PtdSer. Using this property, we established a Ba/F3 subline that strongly exposed PtdSer by repetitive fluorescence-activated cell sorting. A complementary DNA library was constructed from the subline, and a cDNA that caused Ba/F3 to expose PtdSer spontaneously was identified by expression cloning. The cDNA encoded a constitutively active mutant of TMEM16F, a protein with eight transmembrane segments 5 . Wild-type TMEM16F was localized on the plasma membrane and conferred Ca 21 -dependent scrambling of phospholipids. A patient with Scott syndrome 6, 7 , which results from a defect in phospholipid scrambling activity 8, 9 , was found to carry a mutation at a splice-acceptor site of the gene encoding TMEM16F, causing the premature termination of the protein.
When mouse Ba/F3 cells were treated with 1.0 mM A23187 for 15 min in the presence of 0.5 mM CaCl 2 , the cells underwent necrosis or became propidium iodide (PI)-positive. However, when the same treatment was performed in Ca 21 -free conditions, most of the cells exposed PtdSer and the PI-positive population was low (Fig. 1a) . Chelating intracellular Ca 21 with bis-(o-aminophenoxy)ethane-N,N,N9,N9-tetra-acetic acid acetoxymethyl ester (BAPTA-AM) blocked the PtdSer exposure (Fig. 1b) , indicating that the process required the mobilization of intracellular calcium. This PtdSer exposure was reversible: treatment of the PtdSer-exposing cells with BAPTA-AM at 37 uC for 5 min (Fig. 1c) or culturing them in Ca 21 free medium at 37 uC for 12 h (data not shown) eliminated the PtdSer from the cell surface. These results suggest that under low-Ca 21 conditions, A23187 mobilized the intracellular Ca 21 , which activated a phospholipid scramblase to expose PtdSer. When the intracellular Ca 21 concentration was lowered, the phospholipid scramblase lost activity, and flippases returned the PtdSer to the inner leaflet.
To characterize the PtdSer-exposure process, we used its reversible nature under low-Ca 21 conditions to establish a cell line that overexposed PtdSer. Ba/F3 cells were treated with 1.0 mM A23187 in the absence of calcium, and subjected to fluorescence-activated cell sorting (FACS) based on PtdSer exposure. A population (0.5-5%) that showed intense staining with Annexin V was collected, cultured for 15 h in Ca 21 -free medium, returned to normal medium, and subjected to the next sorting. After this cycle of sorting and expansion had been repeated 12 times, the cells (Ba/F3-PS12) showed roughly 100-fold higher staining with Annexin V than the original Ba/F3 cells (Ba/F3-PS0) on treatment with 125 nM A23187 (Fig. 1d) . The sorting and expansion were repeated another seven times, and the resulting cell line (Ba/F3-PS19) was used for further studies.
There were two possible causes of the strong PtdSer exposure in Ba/ F3-PS19 cells. One was the overexpression or overactivation of phospholipid scramblase, and the other was the inactivation of flippase 10 that transports PtdSer from the outer to the inner leaflet of the plasma membrane. To examine which possibility was correct, DsRed-expressing Ba/F3-PS19 cells were fused with green fluorescent protein (GFP)-labelled parental Ba/F3 (Ba/F3-PS0) cells. The PtdSer-exposure response of the hybrid cells to 1.0 mM A23187 was similar to, or slightly weaker than, that of Ba/F3-PS19 cells (Fig. 1e) , suggesting that the phenotype of Ba/F3-PS19 cells was dominant to that of Ba/F3-PS0 cells, and that the phospholipid scramblase was overactivated in Ba/F3-PS19 cells. To identify the gene responsible for the enhanced phospholipid scramblase activity, a cDNA library (9.3 3 10 5 clones) was prepared from Ba/F3-PS19 cells, and introduced into the parental Ba/F3 cell line. The stably transformed cells were treated with 125 nM A23187, and a population that stained strongly with Annexin V was sorted (Fig. 1f) . At the third cycle of sorting and expansion (Library-Derived (LD)-PS3), about 35% of the cells exposed PtdSer without A23187 treatment, and this cell population (LD-PS4) was characterized.
LD-PS4 cells carried two or three different cDNAs, but the Tmem16f cDNA (GenBank accession number NM_175344) was present in two independent experiments, suggesting that TMEM16F caused the PtdSer exposure. The two Tmem16f cDNAs identified in the different experiments contained an A-to-G mutation at nucleotide 1226, which caused an aspartic residue to be replaced by glycine at codon 409 (Fig. 2a) . TMEM16A, another member of the TMEM16 family, was recently shown to be a Ca 21 -dependent Cl 2 channel [11] [12] [13] . However, the Cl 2 -channel activity of TMEM16F was lower than that of TMEM16A 14 .
To examine the function of TMEM16F, the wild-type and mutant (D409G) forms of TMEM16F were tagged with Flag or monomeric red fluorescent protein (mRFP) at the carboxy terminus, and expressed in Ba/F3 or human 293T cells. Western blotting of the cell lysates with anti-Flag showed broad bands at 125 and 500 kDa on SDS-PAGE (Fig. 2b) , suggesting that mouse TMEM16F (calculated molecular mass 106 kDa) is glycosylated and/or aggregated. Observation of the 293T cells expressing TMEM16F-mRFP indicated that TMEM16F is located at the plasma membrane (Fig. 2c) .
Annexin V was able to bind to the Ba/F3 cells expressing the D409G mutant, but not the wild-type, TMEM16F (Fig. 2d) , suggesting that the mutant TMEM16F-expressing cells constitutively expose PtdSer. This was confirmed by binding of MFG-E8, which specifically binds to PtdSer 15, 16 ( Supplementary Fig. 1 ). Chelating the intracellular Ca 21 with BAPTA-AM decreased the exposed PtdSer level in the mutant TMEM16F-expressing cells (Fig. 2d) . When cells expressing wild-type TMEM16F were treated with A23187, PtdSer was exposed without a lag time, reaching saturation more quickly than the vector-transformed Ba/F3 cells (Fig. 2e) . The intracellular Ca 21 concentration and the kinetics of the Ca 21 influx after treatment with A23187 was similar among the vector-transformed cells and those expressing wild-type and D409G mutant TMEM16F (Supplementary Fig. 2 ). These results indicated that TMEM16F mediates a Ca 21 -dependent scramblase activity for PtdSer, and that its D409G mutant is sensitized to respond to the normal intracellular concentration of Ca 21 to expose PtdSer. Phospholipid scramblase mediates the bidirectional transfer between plasma membrane leaflets of all phospholipids. Cells expressing the D409G mutant TMEM16F were stained with Ro09-0198 (Supplementary Fig. 3a) , a tetracyclic polypeptide that specifically binds phosphatidylethanolamine (PtdEtn) 17 , indicating that they constitutively exposed PtdEtn, a phospholipid that, like PtdSer, is normally sequestered to the inner leaflet. Treatment of Ba/F3 cells with A23187 caused exposure of PtdEtn. This process was accelerated by overexpressing wild-type TMEM16F ( Supplementary Fig. 3b ). When 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine (NBD-PtdCho) was added to the culture, it was quickly internalized by the D409G-mutant-expressing cells (Fig. 2f ): of the cell-associated NBD-PtdCho, more than 40% became resistant to extraction with BSA within 6 min. When the cells expressing wild-type TMEM16F were treated with A23187, they incorporated NBD-PtdCho faster than the parental cells, and about 40% of the cell-associated NBD-PtdCho was inside the cells within 4 min (Fig. 2g) . Similar results-that is, constitutive internalization by cells expressing the mutant TMEM16F, and enhanced A23817-induced incorporation by cells expressing wild-type TMEM16F-were obtained with N-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sphingosine-1-phosphocholine (NBD-SM) (Supplementary Fig. 4 ). The internalized NBD-PtdCho and NBD-SM were intact ( Supplementary Fig. 5 ). Dynasore, which inhibits dynaminmediated endocytosis 18 inhibited the internalization of these phospholipids only slightly or not at all ( Supplementary Fig. 6 ), suggesting that the contribution of endocytosis to TMEM16F-mediated phospholipid internalization may not be great.
Expression of endogenous TMEM16F in Ba/F3 cells was then knocked down by expressing Tmem16f short hairpin RNA (shRNA). As shown in Fig. 3a and Supplementary Fig. 7 , the expression level of Tmem16f messenger RNA in five transformants was decreased to 20-35% of that in the cells expressing the control shRNA. The rate of A23187-induced exposure of PtdSer and PtdEtn was decreased in these transformants (Fig. 3b, c) . Similarly, the uptake of NBD-PtdCho and NBD-SM was slower in Tmem16f shRNA-transformed cells (Fig. 3d, e) .
Platelets and other blood cells from patients with Scott syndrome show a defect in their ability to expose PtdSer in response to a Ca 21 ionophore 7, 19 . B-cell lines have been established from a patient with Scott syndrome and from the patient's parents 20 . In agreement with previous reports 8, 20 , the patient-derived cells did not expose PtdSer in response to a Ca 21 ionophore (Fig. 4a ). In contrast, A23187 elicited PtdSer exposure in cell lines derived from the patient's parents at the same levels as in cell lines from healthy volunteers. An RT-PCR analysis of the TMEM16F mRNA (GenBank accession number NM_001025356) showed that the 59 part (1,320 base pairs (bp)), corresponding to exons LETTER RESEARCH 1-12, was identical in the patient and the parents, whereas its 39 half, corresponding to exons 11-20, was shorter in the patient than in the parents (Fig. 4b) . A sequence analysis indicated that the cDNA of the patient lacked the 226-bp sequence corresponding to exon 13. Direct sequencing of the chromosomal DNA indicated that the TMEM16F gene of the patient carried a G-to-T homozygous mutation at the splice-acceptor site in intron 12, whereas both parents were heterozygous for the mutation at this position (Fig. 4c) . PCR analysis of the TMEM16F mRNA with primers at exons 12 and 16 showed a 608-bp band from the control and a 382-bp band from the cell line from the patient with Scott syndrome (Fig. 4d) , indicating that a mutation in the splice acceptor site caused exon 13 to be skipped. This skipping caused a frame shift resulting in the premature termination of the protein in exon 14 ( Fig. 4e) at the third transmembrane segment of human TMEM16F (Fig. 4f) . The nonsense-mediated mRNA decay 21 may explain the decreased concentration of the exon-13-deleted form of TMEM16F mRNA in the patient's parents (Fig. 4d) .
Repeated FACS analysis has been used previously to establish cell lines that overexpress a particular cell-surface protein 22, 23 . Here, this method yielded TMEM16F carrying a point mutation that rendered the process extremely sensitive to Ca 21 , such that in the cells expressing the mutated TMEM16F the phospholipid scramblase functioned even in resting cells, in which the cytosolic Ca 21 concentration was below 100 nM (ref. 24) . The TMEM16 family, to which TMEM16F belongs, consists of ten members in humans and mice 5 . The founding member of the family, human TMEM16A, is a Ca 21 -dependent Cl 2 channel [11] [12] [13] . Although the direct binding of Ca 21 to TMEM16 members has yet to be demonstrated, the amino-terminal region of TMEM16A seems to have a regulatory role 25 . Similarly, the increased sensitivity of the D409G mutant to Ca 21 suggests that either Ca 21 or a Ca 21 -sensing molecule binds to this N-terminal region of TMEM16F. The overexpression of TMEM16A in Ba/F3 cells had no effect on the ionophore-induced exposure of PtdSer (data not shown), suggesting that different members of this family have distinct functions. The PtdSer exposure or scrambling of phospholipids occurs in other biological processes 1, 4, [26] [27] [28] [29] , such as apoptotic cell death, the fusion of muscle, bone or trophoblast cells, and the release of neurotransmitters and microvesicles. It will be . A23187 was added, incubated and diluted with fatty-acid-free BSA buffer, and fluorescence was determined. Experiments in b-e were performed at least three times. . After dilution with fatty-acid-free BSA buffer, the fluorescence intensity was determined by FACS. g, Vector-transformed or wild-type TMEM16F-expressing Ba/F3 cells were preincubated at 4 uC with 0.1 mM NBD-PtdCho. A23187 (A23) was added and incubated for 8 min at room temperature, and internalized NBD-PtdCho was determined as above. In f and g the percentage of BSA-non-extractable NBD-PtdCho was determined in triplicate at 4 min (f) or 6 min (g) after the addition of NBD-PtdCho and is plotted as mean and s.d. All experiments were performed at least three times.
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interesting to study whether TMEM16F and/or its related members in the TMEM16 family are involved in these processes.
METHODS SUMMARY
To expose PtdSer reversibly on the cell surface, Ba/F3 cells were treated at 37 uC with A23187 under Ca . The TMEM16F mRNA in these cell lines was analysed by RT-PCR. The TMEM16F chromosomal gene was amplified by PCR from the genomic DNA of the cell lines, and was directly sequenced by cycle sequencing with an ABI 3100 genetic analyser (Applied Biosystems). Exposure of PtdSer and PtdEtn on the cell surface was analysed by the binding of Cy5-labelled Annexin V and biotin-labelled Ro09-0198 (ref. 17) , respectively. The internalization of NBD-PtdCho and NBD-SM was analysed by the BSA-extraction method essentially as described 30 . For the knock-down experiment, shRNA-retrovirus vectors for Tmem16f and control scrambled sequence were obtained from OriGene, and the resultant retrovirus was used to infect Ba/F3 cells. 20 from a patient with Scott syndrome and the patient's parents were grown in RPMI1640 medium containing 10% FCS and 50 mM 2-mercaptoethanol. Human 293T cells and Plat-E packaging cells 31 were cultured in DMEM medium containing 10% FCS. Recombinant mouse IL-3 was produced by mouse C127I cells transformed with a bovine papillomavirus expression vector bearing mouse Il-3 cDNA as described 32 . Biotin-labelled Ro09-0198 was prepared as described previously 33 . Flag-tagged mouse MFG-E8 was produced in human 293T cells as described 34 , and the secreted MFG-E8 was purified with anti-Flag M2 beads (Sigma-Aldrich Ba/F3 cells in HBSS had been treated at 37 uC for 15 min with A23187, they were suspended in 1 ml of Annexin V staining buffer that had been prechilled to 4 uC. The cells were stained with Cy5-Annexin V on ice as described above, and sorted with a FACSAria whose injection chamber was kept at 4 uC. Cells providing the highest level of Cy5 fluorescence signal (the top 0.5-5.0%) were collected and resuspended at a density of more than 10 5 cells ml 21 in Ca
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-free RPMI containing 5% dialysed FCS, 45 U ml 21 IL-3 and 50 mM 2-mercaptoethanol. After 24 h the cells were resuspended in normal Ca 21 -containing RPMI medium and expanded for the next sorting. Construction of the cDNA library. Total RNA was prepared from Ba/F3 PS19 cells with an RNeasy Mini Kit (Qiagen), and poly(A)
1 RNA was purified with an mRNA Purification Kit (GE Healthcare) with two cycles of oligo(dT)-cellulose column chromatography. Double-stranded cDNA was synthesized with random hexamers as primers, using a cDNA synthesis kit (SuperScript Choice System for cDNA Synthesis; Invitrogen). A BstXI adaptor was attached, and the fragments were size-fractionated by electrophoresis through a 1% agarose gel (Seakem GTG agarose; Lonza). DNA fragments longer than 2.5 kb were recovered from the gel with a DNA extraction kit (Wizard SV Gel and PCR Clean-up System; Promega) and ligated into a BstXI-digested pMXs vector 35 . Escherichia coli DH10B cells (ElectroMax DH10B; Invitrogen) were transformed by electroporation with a Gene Pulser (Bio-Rad). About 9.3 3 10 5 clones were produced, and plasmid DNA was prepared with a QIAfilter Plasmid Maxi Kit (Qiagen). Cell fusion. Ba/F3-PS0 and Ba/F3-PS19 cells were transduced with pMXs-puro EGFP and pMXs-neo DsRed, respectively, and cultured in the presence of 1 mg ml 21 puromycin or 1 mg ml 21 G418. Ba/F3-PS0 EGFP cells and Ba/F3-PS19 DsRed cells were fused in the presence of PEG1500 and cultured in the presence of 1 mg ml 21 puromycin and 1 mg ml 21 G418. The EGFP/DsRed double-positive cells were sorted with a FACSAria. Screening of cDNA library. Plasmid DNA (108 mg) from the cDNA library was introduced by lipofection with FuGENE6 (Roche Diagnostics) into 7.2 3 10 7
PLAT-E packaging cells 31 grown in eighteen 10-cm dishes. Two days after the transfection, the viruses in the culture supernatant were centrifuged at 4 uC and 6,000g for 16 h, resuspended in RPMI1640 medium containing 10% FCS and 45 U ml 21 IL-3, and used to infect 7.2 3 10 6 Ba/F3 cells in the presence of 8 mg ml 21 Polybrene (Sigma-Aldrich). After a 24-h culture, the medium was replaced with fresh medium, and the cells were further cultured for 2 days. The sorting of cells that were sensitive to ionophore-induced PtdSer exposure was performed as described above. Isolation of cDNA fragments from Annexin V-positive Ba/F3 cells. To isolate the cDNA integrated into the retroviral vector, the genomic DNA was extracted from Ba/F3 cell transformants with the Wizard Genomic DNA Purification System (Promega) and subjected to PCR with the Expand Long Template PCR System (Roche Diagnostics). The PCR primers (59-CCCGGGGGTGGACCATCCTCT-39 and 59-CCCCTTTTTCTGGAGACTAAAT-39) carried sequences from the pMXs vector, and the conditions for PCR were 10 s at 96 uC, 30 s at 58 uC and 4 min at 68 uC for 35 cycles. The PCR fragments were cloned into the pGEM-T Easy vector (Promega) and subjected to DNA sequencing analysis with an ABI PRISM 3100 Genetic Analyser (Applied Biosystems). Expression vector for TMEM16F and its mutants. The Flag-tag sequence was integrated into the EcoRI and XhoI sites of the retroviral vector pMXs-puro, resulting in pMXs-puro c-Flag. The full-length coding sequence for mouse TMEM16F (GenBank accession number NM_175344) was prepared by RT-PCR with the mRNA from Ba/F3 cells. The primers used were as follows (in each primer the EcoRI recognition sequence is underlined): 59-ATATGAATTCGACATGCAGATG ATGACTAGGAA-39 and 59-ATATGAATTCGAGTTTTGGCCGCACGCTGT-39.
The PCR fragments were inserted into the EcoRI site of pMXs-puro c-Flag, and the authenticity of the cDNAs was verified by DNA sequencing.
For the expression plasmid of TMEM16F-mRFP, the coding sequence for mRFP in pcDNA-mRFP (Invitrogen) was joined in-frame to the C terminus of mouse TMEM16F and introduced into pMXs vector. Expression in mouse Ba/F3 and human 293T cells. The expression vector for Flag-tagged TMEM16F in pMXs-puro was introduced into Plat-E cells. The retrovirus produced was concentrated as described above and used to infect Ba/F3 cells to establish stable transformants. The transformants were selected by culturing the cells in medium containing puromycin (1.0 mg ml
). To express TMEM16F-mRFP, human 293T cells were transfected by lipofection with FuGENE6 with the pMXs vector carrying the TMEM16F-mRFP sequence. One day later, the transfected cells were observed by fluorescence microscopy (BioRevo BZ-9000; Keyence). Western blotting. Cells were lysed in RIPA buffer (50 mM Hepes-NaOH pH 8.0 containing 1% Nonidet P40, 0.1% SDS, 0.5% sodium deoxycholate, 150 mM NaCl and 10% protease inhibitor cocktail (Complete Mini; Roche Diagnostics)). The lysate was mixed with 5 3 SDS sample buffer (200 mM Tris-HCl pH 6.8, 10% SDS, 25% glycerol, 5% 2-mercaptoethanol, 0.05% bromophenol blue), boiled for 5 min and separated by electrophoresis on a 10% polyacrylamide gel (Bio Craft). After the proteins had been transferred to a poly(vinylidene difluoride) membrane (Millipore), the membranes were probed with horseradish peroxidase-conjugated mouse anti-Flag M2 (Sigma), and peroxidase activity was detected with a Western Lightning enhanced chemiluminescence system (PerkinElmer). RT-PCR of TMEM16F cDNA and sequencing of its chromosomal gene in a patient with Scott syndrome. Total RNA was prepared from EBV-transformed cell lines from a patient with Scott syndrome and from the patient's parents, and from a healthy control. The RNA was reverse-transcribed with Superscript III (Invitrogen), in accordance with the manufacture's protocol, and the TMEM16F cDNA was analysed by PCR with the following sets of primers (in each primer the additional sequence is underlined): Ex1-FW (59-ATATGAATTCGACATGA AAAAGATGAGCAGGAA-39), Ex11/12-RV (59-GCGTTCTTCTTCCTGAGT AA-39), Ex11/12-FW (59-TTACTCAGGAAGAAGAACGC -39), Ex20-RV (59-ATATGAATTCTTCTGATTTTGGCCGTAAAT-39), Ex12-FW (59-TCTGTG CCAGTGCTGTCTTT-39) and Ex16-RV (59-CTGCAGATGGTAGTCCTGTT-39).
For the sequence analysis of the human TMEM16F chromosomal gene, genomic DNA was prepared from human cell lines and a 965-bp DNA fragment carrying the 226-bp exon 13 and its 59-flanking and 39-flanking regions (about 370 bp each) was amplified by PCR with the following primers: 59-CCA GAGTATGCTACTAGTTG-39 and 59-TCTCAGCAACCGAGGAACAT-39. The PCR products were purified with a Wizard SV PCR and Gel Clean-up System. Cycle sequencing was performed with a BigDye Terminator v3.1 Cycle Sequencing kit with a primer of 59-GGACCTTACCGAAGTTAGTA-39, and analysed with an ABI PRIZM 3100 Genetic Analyser. Analysis of exposure of PtdSer and PtdEtn. To analyse the exposure of PtdSer and PtdEtn, 10 5 cells at early exponential phase were washed with PBS, suspended in 1.0 ml of cold Annexin V staining buffer with 2,500-5,000-fold diluted Cy5-labelled Annexin V or 800-fold diluted biotin-Ro09-0198 (ref. 33 ) followed by 1.0 mg ml 21 APC-labelled streptavidin and 5 mg ml 21 PI. The samples were incubated on ice for 15 min, and flow cytometry was performed on a FACSAria or FACSCalibur as described above. For binding of MFG-E8, the cells were suspended in RPMI1640 containing 10% FCS and then incubated on ice for 20 min with Flag-tagged D89E mutant of MFG-E8 (0.4 mg ml 21 ) 34 . The cells were washed with the above medium and incubated on ice for 20 min with 1.0 mg ml 21 hamster monoclonal antibody against mouse MFG-E8 (clone 2422). This was followed by incubation with phycoerythrin-labelled mouse anti-hamster IgG (BD Bioscience) and analysis by flow cytometry with a FACSAria.
To study the requirement for intracellular Ca
, 10 5 cells were incubated with 10 mM BAPTA-AM in RPMI1640 medium containing 10% FCS at 37 uC for 5 min for the PtdSer exposure, or for 60 min for the PtdEtn exposure. The cells were LETTER RESEARCH washed with Annexin V staining buffer, and stained with Cy5-Annexin V or biotin-Ro09-0198 as described above.
For the kinetic study of the Ca
-induced PtdSer and PtdEtn exposure, 10 6 cells were washed with PBS, suspended in 1.0 ml of cold Annexin V staining buffer with Cy5-labelled Annexin V or a mixture of biotin-Ro09-0198 and APC-labelled streptavidin, and 5 mg ml 21 PI. Cells were mixed on ice with A23187 at a final concentration of 0.25 or 0.5 mM, and applied to the injection chamber of a FACSAria that was set at 20 uC (for Ba/F3 cells) or 37 uC (for human cell lines) to induce the A23187 reaction. Data were recorded for the indicated periods, and the PI-positive cells were excluded from the analysis. Internalization of NBD-PtdCho and NBD-SM. The internalization of NBDlipid analogues was analysed by flow cytometry essentially as described in refs 8 and 30. In brief, 10 6 cells were washed with HBSS and resuspended in 0.5 ml of HBSS containing 2 mM CaCl 2 (HBSS-Ca). An equal volume of HBSS-Ca containing 1 mM NBD-PtdCho or NBD-SM was added to the cell suspension and incubated at room temperature. At each time point, 150 ml of cell suspension was collected, mixed with 150 ml of the prechilled (4 uC) HBSS-Ca containing 5 mg ml 21 fatty-acid-free BSA (Sigma-Aldrich), to extract the unincorporated fluorescent lipids, and 500 nM Sytoxblue (Molecular Probes). To measure the total fluorescence, samples were mixed with HBSS-Ca in the absence of BSA. After incubation for 10 min at 4 uC to extract the lipid, the cells were analysed with a FACSAria for forward scatter, side scatter, logarithmic green fluorescence (NBD), and Sytoxblue fluorescence. The Sytoxblue-positive dead cells were excluded from the analysis. The fluorescence of NBD-phospholipids that were resistant to the BSA extraction was regarded as representing phospholipids that had been incorporated into cells.
To examine the effect of the Ca 21 ionophore, 5 3 10 5 cells were washed with HBSS-Ca, resuspended in 0.5 ml of cold HBSS-Ca, and incubated on ice for 7 min. Cold HBSS (0.5 ml) containing 0.2 mM NBD-PtdCho or NBD-SM was added to the cell suspension and incubated further on ice for 3 min. The cells were then mixed with A23187 and incubated at room temperature to induce lipid incorporation. A 150-ml aliquot was used to determine the incorporated lipid quantity as described above. Thin-layer chromatography. After incubation of cells with NBD-PtdCho or NBD-SM, the phospholipids were extracted from the cells by incubation at room temperature for 30 min with a mixture of chloroform, methanol and water (5:10:4, by volume). The phospholipids were separated by thin-layer chromatography on a silica gel 60 plate (Merck) with chloroform/acetone/methanol/acetic acid/water (5:2:1:1:0.5 by volume) as a solvent. The fluorescence on the plate was detected with a LAS4000 image analyser (Fuji Film). Intracellular Ca 21 and Ca 21 influx. To determine the intracellular Ca 21 concentration, 10 6 cells were suspended in HBSS, incubated at 37 uC for 10 min with 0.4 mM Fluo-4-AM (Molecular Probes), washed with HBSS, and analysed with a FACSAria.
The Ca 21 influx was measured as described 36 . In brief, 10 6 cells were labelled for 30 min at 37 uC with 1 mM Fluo-4-AM in RPMI containing 10% FCS. After being washed with the Annexin V staining buffer, the cells were kept at 4 uC in Annexin V staining buffer. The Ca 21 ionophore A23187 was added to the mixture at a final concentration of 0.5 mM, and the change in mean fluorescence intensity was directly recorded with a FACSCalibur system. The data was analysed with FlowJo Software. shRNA. shRNA expression plasmids for mouse Tmem16f in a pRS shRNA vector carrying the puromycin-resistance gene were purchased from OriGene. The target sequence of the shRNA for Tmem16f was 59-CATCTACTCTGTGAAGTTC TTCATTTCCT-39. The scrambled non-effective shRNA (59-GCACTACCAGA GCTAACTCAGATAGTACT-39) in pRS was from OriGene. Ba/F3 cells were infected with retrovirus containing the shRNA, and cultured in the presence of 1.0 mg ml 21 puromycin. Puromycin-resistant cells were subjected to cloning by limited dilution. The Tmem16f mRNA was quantified by real-time PCR, and the clones that showed the decreased expression were used for further study.
